SYNCOMF19.23

Syncom Formulations (India) Limited

· Pharma & Health
₹ CrorePeersHESTERBIONGLFINEWINDLASJAGSNPHARMAMRUTANJANINDOCOSAIPARENTMcap ₹1,808 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment72.377.589.889.8
+ Investment Property47.347.393.393.3
+ Other Intangibles0.10.00.40.4
+ Non-current Investments2.53.62.52.5
+ Other Non-current Financial Assets7.414.016.116.1
Non-current Financial Assets9.917.618.718.7
+ Other Non-current Assets0.20.81.31.3
Total Non-current Assets129.9143.3203.5203.5
Current Assets
+ Inventories21.141.362.962.9
+ Current Investments63.789.2106.5106.5
+ Trade Receivables103.3107.5110.5110.5
+ Cash & Cash Equivalents63.40.75.15.1
+ Other Bank Balances4.50.01.21.2
+ Short-term Loans4.35.47.07.0
+ Other Current Financial Assets4.13.53.83.8
Current Financial Assets243.3206.4234.2234.2
+ Other Current Assets10.422.233.333.3
Total Current Assets274.8270.0330.4330.4
Total Assets404.7413.3533.8533.8
Equity
+ Equity Share Capital94.094.094.094.0
+ Other Equity / Reserves194.1248.2321.0321.0
Equity — Owners of Parent288.1342.2415.0415.0
Total Equity288.1342.2415.0415.0
Liabilities
+ Other Non-current Financial Liab1.71.31.61.6
Non-current Financial Liabilities1.71.31.61.6
+ Provisions — Non-current3.34.25.45.4
+ Deferred Tax Liabilities5.06.38.18.1
+ Other Non-current Liabilities0.00.00.00.0
Non-current Liabilities10.011.815.115.1
+ Borrowings — Current72.54.61.51.5
+ Trade Payables24.142.874.474.4
+ Other Current Financial Liab2.12.12.22.2
Current Financial Liabilities98.849.578.078.0
+ Provisions — Current3.64.26.46.4
+ Other Current Liabilities4.15.619.319.3
Current Liabilities106.559.3103.7103.7
Total Liabilities116.571.1118.9118.9
Total Equity & Liabilities404.7413.3533.8533.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current22.85.95.9
+ Dues to Other Creditors — Current20.068.568.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.